Making a Difference
Breakthrough Medical Device Innovation for Rheumatic and Degenerative Heart Disease
People Affected Worldwide by RHD & DHD
Patients Operated Worldwide per year
Patients in Need Worldwide per year
Transcatheter Aortic Valve Replacement
Juvenile sheep with with Rheumatic Heart Disease
As a world-first, SAT offers cost effective and durable transcatheter aortic valve solutions for RHD and DHD patients, in both developed and emerging economies. Specifically, the second generation balloon expandable TAVR valve for rheumatic and degenerative aortic valve disease is designed to treat the entire aortic valve disease spectrum from calcific aortic stenosis to pure aortic regurgitation in patients with non-calcified, compliant annuli.